Lymphoma Clinical Trials

A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 173 clinical trials
None
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Background Lymphoma is a type of blood cancer. Blood cell transplant can cure some people with lymphoma. Researchers want to see if they can limit the

cancer
bone marrow procedure
t-cell lymphoma
graft versus host disease
lymphoma
  • 3 views
  • 24 Nov, 2021
  • 2 locations
None
A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies (PLATFORM)

This is a global, open-label, multi-arm, parallel multi-cohort, multi-center, Phase 1/2 study to determine the safety, tolerability, PK, efficacy and patient-reported quality of life of JCAR017 in combination with various agents. This protocol is intended to evaluate various drug combinations with JCAR017, as separate arms, over the life of the …

cancer
indolent non-hodgkin lymphoma
ibrutinib
hodgkin's disease
ct scan
  • 39 views
  • 30 Nov, 2021
  • 10 locations
None
Venetoclax Ibrutinib Prednisone Obinutuzumab and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

Background B-cell lymphoma is a cancer of white blood cells found in the lymph nodes. It affects the system that fights infections and disease. Researchers want to

gm-csf
cancer
bone marrow procedure
neutrophil count
ibrutinib
  • 71 views
  • 21 Nov, 2021
  • 1 location
None
Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

This is a Phase II single-arm open-label study of nivolumab as maintenance therapy after autologous stem cell transplantation in patients with Hodgkin lymphoma at risk of relapse or progression

high dose chemotherapy
chemotherapy regimen
lymphoma
cell transplantation
renal function
  • 94 views
  • 25 Nov, 2021
  • 6 locations
None
Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma

This study is being done to test the safety and effectiveness of pembrolizumab followed by radiation therapy in Hodgkin lymphoma. The purpose of this study is to determine how effective

classical hodgkin lymphoma
refractory hodgkin lymphoma
chemotherapy regimen
lymphoma
granulocyte colony stimulating factor
  • 61 views
  • 28 Nov, 2021
  • 9 locations
None
Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

with indolent lymphoma and diffuse large B-cell lymphoma (DLBCL) and to evaluate the efficacy of magrolimab in combination with R-GemOx in aspartate aminotransferase (ASCT) ineligible DLBCL

cancer
indolent lymphoma
hodgkin's disease
large b-cell lymphoma
combination chemotherapy
  • 166 views
  • 30 Nov, 2021
  • 34 locations
None
Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy

naive Follicular Lymphoma. The study will involve an induction phase and a maintenance phase for responding participants, for up to 24 months. Response to treatment will be monitored using

follicular lymphoma
tositumomab
platelet count
conjugated bilirubin
obinutuzumab
  • 0 views
  • 15 Nov, 2021
  • 4 locations
None
A Study of OLR in First-line Treatment of Mantle Cell Lymphoma

This is a single-arm, multicenter, open label phase II clinical study to evaluate the efficacy and safety of OLR in the treatment of initially treated mantle cell lymphoma.

rituximab
lenalidomide
measurable disease
mantle cell lymphoma
  • 0 views
  • 19 Nov, 2021
  • 1 location
None
LCCC1841: A Phase 2 Trial of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas

lymphomas, and the results were promising. Acalabrutinib and ibrutinib attack a similar target found in CNC lymphoma. Research studies show that acalabrutinib does a better job in attacking this target than

cancer
neutrophil count
mantle cell lymphoma
anticancer agents
ibrutinib
  • 0 views
  • 28 Nov, 2021
  • 3 locations
None
Venetoclax Ibrutinib Prednisone Obinutuzumab and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma

Background Aggressive B-cell lymphomas can be cured but people with disease that resists treatment or that returns after treatment have poor outcomes with standard

fludeoxyglucose f-18
cancer
gm-csf
bone marrow procedure
neutrophil count
  • 0 views
  • 21 Nov, 2021
  • 1 location